

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 6.70889136 |
| 2 | cellular extravasation (GO:0045123) | 6.55484359 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.24362002 |
| 4 | response to peptidoglycan (GO:0032494) | 5.82063693 |
| 5 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.69652815 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39915709 |
| 7 | positive regulation of mast cell activation (GO:0033005) | 5.15343881 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05588692 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.05588692 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.00213462 |
| 11 | respiratory burst (GO:0045730) | 4.98397389 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.88702108 |
| 13 | defense response to fungus (GO:0050832) | 4.87850489 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.86851923 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.82219096 |
| 16 | neutrophil mediated immunity (GO:0002446) | 4.73429551 |
| 17 | positive regulation of mast cell degranulation (GO:0043306) | 4.65162807 |
| 18 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.65162807 |
| 19 | regulation of mast cell degranulation (GO:0043304) | 4.59845627 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.58170002 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58170002 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58170002 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58170002 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.58170002 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58170002 |
| 26 | detection of external biotic stimulus (GO:0098581) | 4.55382737 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.49288708 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 4.42321145 |
| 29 | neutrophil activation (GO:0042119) | 4.41935575 |
| 30 | regulation of mast cell activation (GO:0033003) | 4.39194115 |
| 31 | response to fungus (GO:0009620) | 4.38255107 |
| 32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.35565741 |
| 33 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.30590322 |
| 34 | leukotriene metabolic process (GO:0006691) | 4.24185720 |
| 35 | response to interleukin-15 (GO:0070672) | 4.21187544 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.20622124 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 4.18989232 |
| 38 | microglial cell activation (GO:0001774) | 4.18434154 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 4.17715740 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.16209417 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.12124555 |
| 42 | response to host immune response (GO:0052572) | 4.12124555 |
| 43 | granulocyte activation (GO:0036230) | 4.09140549 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 4.06958344 |
| 45 | detection of biotic stimulus (GO:0009595) | 4.03542374 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.99232358 |
| 47 | superoxide anion generation (GO:0042554) | 3.96430230 |
| 48 | neutrophil chemotaxis (GO:0030593) | 3.93395957 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.90982589 |
| 50 | cellular response to interleukin-15 (GO:0071350) | 3.90234788 |
| 51 | neutrophil migration (GO:1990266) | 3.81343208 |
| 52 | macrophage activation (GO:0042116) | 3.80263009 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.80100957 |
| 54 | lipoxygenase pathway (GO:0019372) | 3.75789838 |
| 55 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.73223624 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.71451623 |
| 57 | response to host (GO:0075136) | 3.71451623 |
| 58 | response to host defenses (GO:0052200) | 3.71451623 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71381024 |
| 60 | leukotriene biosynthetic process (GO:0019370) | 3.68552966 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.58465506 |
| 62 | macrophage differentiation (GO:0030225) | 3.45811488 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45648295 |
| 64 | myeloid leukocyte mediated immunity (GO:0002444) | 3.45490208 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42015156 |
| 66 | negative regulation of phagocytosis (GO:0050765) | 3.41647281 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.41556271 |
| 68 | positive regulation of leukocyte degranulation (GO:0043302) | 3.41231297 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40700537 |
| 70 | regulation of regulated secretory pathway (GO:1903305) | 3.35218039 |
| 71 | chronic inflammatory response (GO:0002544) | 3.35195221 |
| 72 | granulocyte migration (GO:0097530) | 3.34860784 |
| 73 | negative regulation of granulocyte differentiation (GO:0030853) | 3.34318823 |
| 74 | tolerance induction (GO:0002507) | 3.33978277 |
| 75 | B cell mediated immunity (GO:0019724) | 3.33769817 |
| 76 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.33736927 |
| 77 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.30358540 |
| 78 | leukocyte cell-cell adhesion (GO:0007159) | 3.29622952 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.29310778 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.29310778 |
| 81 | response to muramyl dipeptide (GO:0032495) | 3.29050441 |
| 82 | response to type I interferon (GO:0034340) | 3.27426113 |
| 83 | granulocyte chemotaxis (GO:0071621) | 3.27292886 |
| 84 | regulation of tolerance induction (GO:0002643) | 3.26440076 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 3.25786405 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.22580679 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.22580679 |
| 88 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.20600487 |
| 89 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.20600487 |
| 90 | detection of other organism (GO:0098543) | 3.15066601 |
| 91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14810536 |
| 92 | detection of bacterium (GO:0016045) | 3.12644826 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 3.11815662 |
| 94 | positive regulation of antigen processing and presentation (GO:0002579) | 3.10215071 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.08655341 |
| 96 | negative regulation of interleukin-1 production (GO:0032692) | 3.07708069 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 3.05532910 |
| 98 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05103885 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.03941398 |
| 100 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.03332715 |
| 101 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02807262 |
| 102 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.02766638 |
| 103 | negative regulation of interleukin-6 production (GO:0032715) | 3.02081952 |
| 104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01633700 |
| 105 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01229159 |
| 106 | positive regulation of interferon-alpha production (GO:0032727) | 3.01066074 |
| 107 | negative regulation of innate immune response (GO:0045824) | 3.00187454 |
| 108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99317838 |
| 109 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98066120 |
| 110 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98066120 |
| 111 | dendritic cell migration (GO:0036336) | 2.97413922 |
| 112 | actin nucleation (GO:0045010) | 2.97168414 |
| 113 | leukocyte mediated cytotoxicity (GO:0001909) | 2.96226208 |
| 114 | sequestering of metal ion (GO:0051238) | 2.92537991 |
| 115 | germinal center formation (GO:0002467) | 2.89521429 |
| 116 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88153196 |
| 117 | myeloid cell activation involved in immune response (GO:0002275) | 2.86356940 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86321846 |
| 119 | activated T cell proliferation (GO:0050798) | 2.86067541 |
| 120 | negative regulation of mast cell activation (GO:0033004) | 2.83252380 |
| 121 | regulation of antigen processing and presentation (GO:0002577) | 2.81009091 |
| 122 | B cell receptor signaling pathway (GO:0050853) | 2.80913294 |
| 123 | dendritic cell chemotaxis (GO:0002407) | 2.77092039 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73571235 |
| 125 | adaptation of signaling pathway (GO:0023058) | 2.73196420 |
| 126 | reactive oxygen species biosynthetic process (GO:1903409) | 2.71466547 |
| 127 | mannose metabolic process (GO:0006013) | 2.69843438 |
| 128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.66442988 |
| 129 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65558319 |
| 130 | myeloid leukocyte migration (GO:0097529) | 2.65358379 |
| 131 | leukocyte degranulation (GO:0043299) | 2.63399653 |
| 132 | leukocyte chemotaxis (GO:0030595) | 2.59196849 |
| 133 | leukocyte mediated immunity (GO:0002443) | 2.58831283 |
| 134 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.53429829 |
| 135 | positive regulation of regulated secretory pathway (GO:1903307) | 2.53019499 |
| 136 | pinocytosis (GO:0006907) | 2.51760136 |
| 137 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.51713902 |
| 138 | lymphocyte mediated immunity (GO:0002449) | 2.48793275 |
| 139 | defense response to protozoan (GO:0042832) | 2.48370217 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44289996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.93832729 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.92491643 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.43920882 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49804843 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.36916613 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.18356384 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.12144105 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08018415 |
| 9 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.82036903 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80582488 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.79871922 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.74129857 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64616691 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57535582 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.56608308 |
| 16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.48719495 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45553233 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.45205520 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37425579 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33710410 |
| 21 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11156931 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09667170 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08878345 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07608863 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.04884084 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03949332 |
| 27 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03300916 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94731458 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.92176487 |
| 30 | * MAF_26560356_Chip-Seq_TH1_Human | 1.91892575 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.85322486 |
| 32 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84778364 |
| 33 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81566031 |
| 34 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.75929550 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75613487 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.75463174 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68448988 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.67180596 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64826940 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64510447 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61473244 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54898824 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54243687 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53581010 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53016895 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52670377 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50923625 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50316742 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47907050 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46062275 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44796705 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44551175 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41808672 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41060827 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40667852 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.40557670 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.39984671 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39679777 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37539050 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36212345 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33588326 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32172729 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31394916 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31384250 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31106708 |
| 66 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29492016 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29395952 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24954253 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24020928 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22277235 |
| 71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.22176452 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22068107 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19915180 |
| 74 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19080190 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18760863 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16256146 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16247423 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16162937 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15619008 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15307506 |
| 81 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.15068049 |
| 82 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14639710 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11554074 |
| 84 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11083252 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10443861 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07751729 |
| 87 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.07316786 |
| 88 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.07316786 |
| 89 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.07316786 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06911631 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06422598 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04679451 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04627448 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03986929 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03525419 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03362837 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02746139 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02713272 |
| 99 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02681007 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02439226 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02148618 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01320731 |
| 103 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01287326 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00492940 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99913439 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95346830 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93631191 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93032689 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92426246 |
| 110 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92077644 |
| 111 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91324140 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91269627 |
| 113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.91082639 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89899308 |
| 115 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89857826 |
| 116 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.89005719 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87746620 |
| 118 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.85854624 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.84398645 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84045605 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84031652 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83991718 |
| 123 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83563579 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80842916 |
| 125 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79150235 |
| 126 | P300_27268052_Chip-Seq_Bcells_Human | 0.78937804 |
| 127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78553420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.33043176 |
| 2 | MP0003436_decreased_susceptibility_to | 4.21657045 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.33099598 |
| 4 | MP0009278_abnormal_bone_marrow | 3.13699621 |
| 5 | MP0002419_abnormal_innate_immunity | 3.09993243 |
| 6 | MP0009785_altered_susceptibility_to | 3.09772566 |
| 7 | MP0005025_abnormal_response_to | 2.75192451 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.70696725 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.69923628 |
| 10 | MP0001790_abnormal_immune_system | 2.65247501 |
| 11 | MP0005387_immune_system_phenotype | 2.65247501 |
| 12 | MP0001800_abnormal_humoral_immune | 2.57834019 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.46687240 |
| 14 | MP0001853_heart_inflammation | 2.38476232 |
| 15 | MP0000685_abnormal_immune_system | 2.36999486 |
| 16 | MP0001819_abnormal_immune_cell | 2.36024453 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.34866048 |
| 18 | MP0002405_respiratory_system_inflammati | 2.31382164 |
| 19 | MP0002723_abnormal_immune_serum | 2.29659362 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.29267267 |
| 21 | MP0003724_increased_susceptibility_to | 2.27422838 |
| 22 | MP0005671_abnormal_response_to | 2.12676570 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.08215090 |
| 24 | MP0001545_abnormal_hematopoietic_system | 2.06137558 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.06137558 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.00937668 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.94314591 |
| 28 | MP0003693_abnormal_embryo_hatching | 1.91505089 |
| 29 | MP0004510_myositis | 1.90546724 |
| 30 | MP0002398_abnormal_bone_marrow | 1.90127773 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.89834615 |
| 32 | MP0000716_abnormal_immune_system | 1.83333528 |
| 33 | MP0000343_altered_response_to | 1.80303349 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.77287661 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.76319549 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.74283613 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.72690033 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.72411465 |
| 39 | MP0006082_CNS_inflammation | 1.71343795 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.67172973 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.65571889 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.62595296 |
| 43 | MP0000858_altered_metastatic_potential | 1.61524461 |
| 44 | MP0002722_abnormal_immune_system | 1.58674956 |
| 45 | MP0002429_abnormal_blood_cell | 1.55387995 |
| 46 | MP0003448_altered_tumor_morphology | 1.49814050 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.48294185 |
| 48 | MP0004947_skin_inflammation | 1.47322859 |
| 49 | MP0001851_eye_inflammation | 1.46630650 |
| 50 | MP0003828_pulmonary_edema | 1.44624776 |
| 51 | MP0000490_abnormal_crypts_of | 1.43969248 |
| 52 | MP0003111_abnormal_nucleus_morphology | 1.43701511 |
| 53 | MP0002933_joint_inflammation | 1.39861218 |
| 54 | MP0008260_abnormal_autophagy | 1.37757774 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.33262333 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.31582054 |
| 57 | MP0008469_abnormal_protein_level | 1.29492420 |
| 58 | MP0001873_stomach_inflammation | 1.29227052 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.28578089 |
| 60 | MP0009764_decreased_sensitivity_to | 1.24722569 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.23754445 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.21867607 |
| 63 | MP0005310_abnormal_salivary_gland | 1.18710667 |
| 64 | MP0003075_altered_response_to | 1.14559652 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.13427655 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.13156612 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.12114781 |
| 68 | MP0009840_abnormal_foam_cell | 1.07540193 |
| 69 | MP0010094_abnormal_chromosome_stability | 1.06245829 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.05147062 |
| 71 | MP0003866_abnormal_defecation | 1.04333644 |
| 72 | MP0005023_abnormal_wound_healing | 1.03071080 |
| 73 | MP0002132_abnormal_respiratory_system | 1.01939969 |
| 74 | MP0003077_abnormal_cell_cycle | 1.00131497 |
| 75 | MP0010307_abnormal_tumor_latency | 0.97813602 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.97464387 |
| 77 | MP0004883_abnormal_blood_vessel | 0.96049098 |
| 78 | MP0003690_abnormal_glial_cell | 0.95412025 |
| 79 | MP0005390_skeleton_phenotype | 0.92750395 |
| 80 | MP0002006_tumorigenesis | 0.89583521 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.87192620 |
| 82 | MP0008004_abnormal_stomach_pH | 0.86668810 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 0.86287195 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.85036000 |
| 85 | MP0001663_abnormal_digestive_system | 0.83851979 |
| 86 | MP0008058_abnormal_DNA_repair | 0.83385529 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.82633472 |
| 88 | MP0003045_fibrosis | 0.82375112 |
| 89 | MP0005166_decreased_susceptibility_to | 0.79318359 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.79266272 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.78557247 |
| 92 | MP0003878_abnormal_ear_physiology | 0.78557247 |
| 93 | MP0004381_abnormal_hair_follicle | 0.78243739 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.77466972 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 0.76348138 |
| 96 | MP0002928_abnormal_bile_duct | 0.75891151 |
| 97 | MP0005083_abnormal_biliary_tract | 0.75655301 |
| 98 | MP0009763_increased_sensitivity_to | 0.75111829 |
| 99 | MP0004130_abnormal_muscle_cell | 0.73005029 |
| 100 | MP0005451_abnormal_body_composition | 0.72739011 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.72248523 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.71405225 |
| 103 | MP0000371_diluted_coat_color | 0.69818952 |
| 104 | MP0000249_abnormal_blood_vessel | 0.67876727 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.67473979 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.67429237 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.67125712 |
| 108 | MP0000313_abnormal_cell_death | 0.61059252 |
| 109 | MP0002653_abnormal_ependyma_morphology | 0.60521938 |
| 110 | MP0003795_abnormal_bone_structure | 0.58911456 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.58550072 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.57611915 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.57296295 |
| 114 | MP0000604_amyloidosis | 0.57018285 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.56753778 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.56136231 |
| 117 | MP0005164_abnormal_response_to | 0.55946450 |
| 118 | MP0008874_decreased_physiological_sensi | 0.53216879 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.49988247 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.49230250 |
| 121 | MP0004484_altered_response_of | 0.49152156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.11851693 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.40714284 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.00471512 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.22200173 |
| 5 | Chronic obstructive pulmonary disease (HP:0006510) | 5.42193362 |
| 6 | Obstructive lung disease (HP:0006536) | 5.42193362 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.07286018 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.70693259 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.67207815 |
| 10 | Hypochromic microcytic anemia (HP:0004840) | 4.58595076 |
| 11 | Gingivitis (HP:0000230) | 4.39176856 |
| 12 | Recurrent skin infections (HP:0001581) | 4.38003303 |
| 13 | Myositis (HP:0100614) | 4.35846952 |
| 14 | Stomatitis (HP:0010280) | 4.29955743 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99408446 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.97045553 |
| 17 | IgM deficiency (HP:0002850) | 3.91635125 |
| 18 | Hypochromic anemia (HP:0001931) | 3.85011731 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.70861978 |
| 20 | Episodic fever (HP:0001954) | 3.56962412 |
| 21 | Pustule (HP:0200039) | 3.54806735 |
| 22 | Meningitis (HP:0001287) | 3.53889757 |
| 23 | Cellulitis (HP:0100658) | 3.48300884 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42389071 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42389071 |
| 26 | Orchitis (HP:0100796) | 3.38314560 |
| 27 | Urticaria (HP:0001025) | 3.30647592 |
| 28 | Petechiae (HP:0000967) | 3.24142964 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.15319902 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11834065 |
| 31 | Spontaneous hematomas (HP:0007420) | 3.11782856 |
| 32 | Optic neuritis (HP:0100653) | 3.05487355 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.05487355 |
| 34 | Peritonitis (HP:0002586) | 3.04414550 |
| 35 | Recurrent viral infections (HP:0004429) | 3.03240789 |
| 36 | Anorexia (HP:0002039) | 3.02807701 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.90095476 |
| 38 | Cheilitis (HP:0100825) | 2.87984442 |
| 39 | Pulmonary embolism (HP:0002204) | 2.77710822 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 2.75325724 |
| 41 | Amyloidosis (HP:0011034) | 2.74915212 |
| 42 | Microcytic anemia (HP:0001935) | 2.72607081 |
| 43 | Periodontitis (HP:0000704) | 2.71925351 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.70985121 |
| 45 | Leukocytosis (HP:0001974) | 2.70784380 |
| 46 | T lymphocytopenia (HP:0005403) | 2.70497664 |
| 47 | Increased IgM level (HP:0003496) | 2.66912430 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.64749977 |
| 49 | Vasculitis (HP:0002633) | 2.64588646 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.55395135 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.50925650 |
| 52 | Reticulocytopenia (HP:0001896) | 2.48205347 |
| 53 | Abnormality of the pleura (HP:0002103) | 2.45707733 |
| 54 | Chronic otitis media (HP:0000389) | 2.45324879 |
| 55 | Encephalitis (HP:0002383) | 2.43493587 |
| 56 | Gangrene (HP:0100758) | 2.41202668 |
| 57 | Agnosia (HP:0010524) | 2.35470965 |
| 58 | Colitis (HP:0002583) | 2.34415467 |
| 59 | Gingival bleeding (HP:0000225) | 2.34178968 |
| 60 | Hepatosplenomegaly (HP:0001433) | 2.33048967 |
| 61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32998303 |
| 62 | Increased IgE level (HP:0003212) | 2.31032597 |
| 63 | Eosinophilia (HP:0001880) | 2.26993835 |
| 64 | Epistaxis (HP:0000421) | 2.26612905 |
| 65 | Glomerulonephritis (HP:0000099) | 2.25501255 |
| 66 | Hemoptysis (HP:0002105) | 2.24860159 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.24020332 |
| 68 | Keratitis (HP:0000491) | 2.23531998 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23078824 |
| 70 | Granulocytopenia (HP:0001913) | 2.21573142 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.20757330 |
| 72 | Abnormality of the endocardium (HP:0004306) | 2.20558198 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.19829216 |
| 74 | Vertigo (HP:0002321) | 2.18825580 |
| 75 | Abnormality of the peritoneum (HP:0002585) | 2.17948275 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16906021 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16906021 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16906021 |
| 79 | Skin ulcer (HP:0200042) | 2.16614787 |
| 80 | Abnormality of T cell physiology (HP:0011840) | 2.14293880 |
| 81 | Osteomyelitis (HP:0002754) | 2.12614652 |
| 82 | Abnormal platelet volume (HP:0011876) | 2.11608073 |
| 83 | Purpura (HP:0000979) | 2.11224600 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.09244371 |
| 85 | Prostate neoplasm (HP:0100787) | 2.09143161 |
| 86 | Acne (HP:0001061) | 2.08116901 |
| 87 | Myelodysplasia (HP:0002863) | 2.07998366 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.06509339 |
| 89 | Glomerulopathy (HP:0100820) | 2.06310724 |
| 90 | Increased serum ferritin (HP:0003281) | 2.05554391 |
| 91 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.05350473 |
| 92 | Abnormality of the pericardium (HP:0001697) | 2.04402220 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.03725728 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03570071 |
| 95 | Abnormal platelet function (HP:0011869) | 2.01667747 |
| 96 | Impaired platelet aggregation (HP:0003540) | 2.01667747 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01412427 |
| 98 | Chromsome breakage (HP:0040012) | 1.99471856 |
| 99 | Abnormality of T cells (HP:0002843) | 1.97715835 |
| 100 | Premature loss of primary teeth (HP:0006323) | 1.97711254 |
| 101 | Nasal polyposis (HP:0100582) | 1.97080737 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.96751348 |
| 103 | Abnormality of the nasal mucosa (HP:0000433) | 1.96748123 |
| 104 | Thickened calvaria (HP:0002684) | 1.96693650 |
| 105 | Stomach cancer (HP:0012126) | 1.96254476 |
| 106 | Acute hepatic failure (HP:0006554) | 1.95096211 |
| 107 | Toxemia of pregnancy (HP:0100603) | 1.94853192 |
| 108 | Chest pain (HP:0100749) | 1.94667932 |
| 109 | Abnormality of eosinophils (HP:0001879) | 1.93709819 |
| 110 | Polyneuropathy (HP:0001271) | 1.92561449 |
| 111 | Sepsis (HP:0100806) | 1.92426322 |
| 112 | Bone marrow hypocellularity (HP:0005528) | 1.92112934 |
| 113 | Thyroiditis (HP:0100646) | 1.91351252 |
| 114 | Lymphopenia (HP:0001888) | 1.90019320 |
| 115 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89010725 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88243915 |
| 117 | Agammaglobulinemia (HP:0004432) | 1.85872331 |
| 118 | Loss of speech (HP:0002371) | 1.85338969 |
| 119 | Pulmonary infiltrates (HP:0002113) | 1.85338963 |
| 120 | Keratoconjunctivitis (HP:0001096) | 1.84294906 |
| 121 | Skin rash (HP:0000988) | 1.83487166 |
| 122 | Hematochezia (HP:0002573) | 1.83125020 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82509346 |
| 124 | Menorrhagia (HP:0000132) | 1.81784996 |
| 125 | Leukopenia (HP:0001882) | 1.81720749 |
| 126 | Arterial thrombosis (HP:0004420) | 1.79496360 |
| 127 | Abnormality of the prostate (HP:0008775) | 1.77440131 |
| 128 | Lymphoma (HP:0002665) | 1.77216732 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.76188687 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76188687 |
| 131 | Recurrent sinusitis (HP:0011108) | 1.75270569 |
| 132 | Basal ganglia calcification (HP:0002135) | 1.74633664 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73169773 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73169773 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73169773 |
| 136 | Slow saccadic eye movements (HP:0000514) | 1.72663030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.70722078 |
| 2 | IRAK4 | 4.64778460 |
| 3 | MAP4K1 | 3.59748199 |
| 4 | IRAK3 | 3.23676220 |
| 5 | RIPK4 | 2.72601132 |
| 6 | FES | 2.27080369 |
| 7 | CSK | 2.24141334 |
| 8 | STK10 | 2.22627407 |
| 9 | BTK | 2.18019912 |
| 10 | FGR | 2.14908235 |
| 11 | MAP2K3 | 2.13518460 |
| 12 | EPHB1 | 2.10766080 |
| 13 | TEC | 2.00481984 |
| 14 | ZAP70 | 1.91294739 |
| 15 | CLK1 | 1.86681749 |
| 16 | TYK2 | 1.85076365 |
| 17 | GRK6 | 1.83257872 |
| 18 | TLK1 | 1.80688595 |
| 19 | TXK | 1.77794192 |
| 20 | TESK2 | 1.71279468 |
| 21 | PIM2 | 1.67814239 |
| 22 | HCK | 1.67757956 |
| 23 | KIT | 1.61941787 |
| 24 | NEK2 | 1.60463804 |
| 25 | PRPF4B | 1.52879492 |
| 26 | SIK3 | 1.48520159 |
| 27 | ERN1 | 1.46063776 |
| 28 | CSF1R | 1.43015855 |
| 29 | BUB1 | 1.38381295 |
| 30 | TBK1 | 1.36766915 |
| 31 | PIM1 | 1.36737155 |
| 32 | MAP3K11 | 1.28930081 |
| 33 | MAP3K1 | 1.20613877 |
| 34 | MAP3K14 | 1.19648517 |
| 35 | TGFBR2 | 1.16444412 |
| 36 | IKBKB | 1.15996545 |
| 37 | SYK | 1.12703714 |
| 38 | TAOK3 | 1.12237166 |
| 39 | KSR2 | 1.11272928 |
| 40 | WEE1 | 1.10078818 |
| 41 | LYN | 1.05717512 |
| 42 | LCK | 1.05097328 |
| 43 | PLK4 | 1.03686647 |
| 44 | PRKD2 | 1.03429659 |
| 45 | PAK4 | 1.01829441 |
| 46 | ITK | 1.01025781 |
| 47 | MARK2 | 1.00131450 |
| 48 | NME2 | 0.96408595 |
| 49 | KDR | 0.95216377 |
| 50 | MARK3 | 0.93691966 |
| 51 | ALK | 0.93519548 |
| 52 | CDK19 | 0.93234183 |
| 53 | LRRK2 | 0.92406763 |
| 54 | EIF2AK1 | 0.90761060 |
| 55 | IRAK2 | 0.89514497 |
| 56 | CDK12 | 0.88895545 |
| 57 | EPHA2 | 0.88324136 |
| 58 | PDK1 | 0.88011914 |
| 59 | JAK3 | 0.86202468 |
| 60 | BMPR2 | 0.81883978 |
| 61 | DAPK2 | 0.80732049 |
| 62 | PTK2B | 0.79125360 |
| 63 | STK16 | 0.78215009 |
| 64 | MAP3K12 | 0.78016681 |
| 65 | MAP3K7 | 0.76761460 |
| 66 | SIK2 | 0.76466193 |
| 67 | MAP3K3 | 0.75969434 |
| 68 | PRKG2 | 0.75677481 |
| 69 | STK11 | 0.75163410 |
| 70 | MAP2K4 | 0.74735940 |
| 71 | PTK6 | 0.72579957 |
| 72 | CAMK1D | 0.72301935 |
| 73 | RPS6KA4 | 0.71561515 |
| 74 | PDPK1 | 0.71107442 |
| 75 | MAP3K13 | 0.70838686 |
| 76 | IKBKE | 0.69062479 |
| 77 | FYN | 0.66752609 |
| 78 | CDK7 | 0.66662787 |
| 79 | PRKCQ | 0.66445456 |
| 80 | GRK7 | 0.65697707 |
| 81 | TRPM7 | 0.65527251 |
| 82 | TTN | 0.64993614 |
| 83 | JAK1 | 0.63940678 |
| 84 | NEK9 | 0.62597654 |
| 85 | MATK | 0.61999029 |
| 86 | MAP3K8 | 0.61040962 |
| 87 | MAPK12 | 0.60840060 |
| 88 | STK4 | 0.60775155 |
| 89 | MAPKAPK2 | 0.58653780 |
| 90 | TSSK6 | 0.57535251 |
| 91 | JAK2 | 0.57450931 |
| 92 | EPHA3 | 0.57204654 |
| 93 | MAP3K2 | 0.56625232 |
| 94 | PIK3CG | 0.55972664 |
| 95 | MAPK7 | 0.55496804 |
| 96 | EIF2AK2 | 0.55276559 |
| 97 | TAOK1 | 0.54943466 |
| 98 | YES1 | 0.52996068 |
| 99 | DYRK1B | 0.52834744 |
| 100 | RPS6KC1 | 0.52137761 |
| 101 | RPS6KL1 | 0.52137761 |
| 102 | HIPK2 | 0.52097570 |
| 103 | RPS6KA6 | 0.50950467 |
| 104 | ZAK | 0.50180972 |
| 105 | NUAK1 | 0.47833839 |
| 106 | STK38 | 0.47075692 |
| 107 | SGK3 | 0.46647602 |
| 108 | PLK1 | 0.42638170 |
| 109 | TNK2 | 0.41792253 |
| 110 | NLK | 0.41590036 |
| 111 | MAP3K5 | 0.40412298 |
| 112 | PRKCZ | 0.39938159 |
| 113 | CDK4 | 0.39422390 |
| 114 | CAMK1G | 0.39367765 |
| 115 | CDC42BPA | 0.39271696 |
| 116 | CAMKK1 | 0.39009071 |
| 117 | CAMKK2 | 0.38792872 |
| 118 | KSR1 | 0.38014097 |
| 119 | PRKCD | 0.37999541 |
| 120 | TAOK2 | 0.37888241 |
| 121 | FRK | 0.36387116 |
| 122 | IRAK1 | 0.35962899 |
| 123 | ARAF | 0.35759142 |
| 124 | STK24 | 0.34913682 |
| 125 | FGFR3 | 0.34878025 |
| 126 | SGK2 | 0.34787029 |
| 127 | GRK1 | 0.34563163 |
| 128 | RET | 0.34064391 |
| 129 | ABL1 | 0.34041618 |
| 130 | PTK2 | 0.33182432 |
| 131 | TRIB3 | 0.32316697 |
| 132 | TTK | 0.31571420 |
| 133 | MAPK4 | 0.31561078 |
| 134 | SMG1 | 0.31474751 |
| 135 | RAF1 | 0.31349486 |
| 136 | MST1R | 0.30673343 |
| 137 | MAPK11 | 0.29808304 |
| 138 | MAP3K6 | 0.29654503 |
| 139 | VRK1 | 0.29631194 |
| 140 | MAP2K6 | 0.29112469 |
| 141 | PRKCH | 0.27975790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.28260747 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14411770 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.79540694 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.24157253 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20064443 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13351345 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98476897 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93208356 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93028095 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 1.85157239 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.83466320 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83002611 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75487976 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.74556818 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71244698 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.67155523 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66404437 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64862188 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64623731 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.63897027 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61698914 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.60902251 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58813595 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.54080096 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.53013808 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.52064872 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48604507 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47501352 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44321100 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.42060539 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.36701581 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36071615 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33930652 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30901941 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.27236032 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.26210058 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24265687 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23202713 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23047475 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.22688655 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.19433972 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.17708048 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13216761 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12000315 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.08168126 |
| 46 | RNA polymerase_Homo sapiens_hsa03020 | 1.07373037 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07079583 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06643107 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05661216 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.04204115 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02949022 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02029659 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98965532 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98665615 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98023139 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.97598709 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96270956 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94793646 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.93024285 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91380647 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91023506 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90268092 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 0.88371668 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.87237887 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86217147 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85350724 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81225153 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79079352 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78001544 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 0.76911934 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75267203 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74978884 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.73005960 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72715554 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72327880 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71501166 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71271085 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71251772 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69608203 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.68966409 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68436864 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67354219 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67254930 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66846948 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65787436 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65642175 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64461164 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62830585 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61806535 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.60824375 |
| 91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60001917 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58868090 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58690232 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58665474 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58452240 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57977503 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56899698 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56094709 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55652521 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55371566 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55141487 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54512973 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53979367 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53818956 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53509939 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.52994563 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52388199 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50610120 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50286832 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50179968 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47148386 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46401980 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45129392 |
| 114 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45127715 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.44818219 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.44532822 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44484438 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43046571 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42296440 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41875250 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41441166 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.40670390 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39895661 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38127683 |
| 125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37687502 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36562420 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35045428 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34784783 |

